Souders Financial Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.85M Sell
5,104
-339
-6% -$116K 0.19% 64
2026
Q1
$1.92M Buy
5,443
+115
+2% +$41K 0.22% 64
2025
Q4
$1.74M Buy
5,328
+88
+2% +$27.9K 0.2% 63
2025
Q3
$1.48M Sell
5,240
-403
-7% -$117K 0.18% 70
2025
Q2
$1.58M Sell
5,643
-520
-8% -$147K 0.2% 62
2025
Q1
$1.92M Sell
6,163
-4,633
-43% -$1.37M 0.27% 57
2024
Q4
$2.81M Sell
10,796
-4,378
-29% -$1.3M 0.39% 59
2024
Q3
$4.89M Buy
15,174
+1,090
+8% +$357K 0.68% 38
2024
Q2
$4.4M Buy
14,084
+11,376
+420% +$3.34M 0.66% 40
2024
Q1
$770K Buy
+2,708
New +$792K 0.12% 109
2023
Q1
Sell
-2,925
Closed -$768K 148
2022
Q4
$768K Buy
+2,925
New +$784K 0.18% 91
2021
Q2
Sell
-1,828
Closed -$455K 133
2021
Q1
$455K Buy
1,828
+311
+21% +$74.2K 0.18% 90
2020
Q4
$349K Buy
1,517
+35
+2% +$8.07K 0.15% 93
2020
Q3
$358K Buy
+1,482
New +$367K 0.17% 87

Other funds holding AMGN

Souders Financial Advisors's AMGN Position: Q2 2026 in Review

Souders Financial Advisors reduced its Amgen (AMGN) stake by 6.2% in Q2 2026, selling an estimated $116K and leaving 5,104 shares worth $1.85M. The position accounts for 0.19% of the portfolio, ranked #64.

Souders Financial Advisors first reported a position in AMGN in Q3 2020 and has held it in 14 quarters since. The position peaked at $4.89M in Q3 2024. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Souders Financial Advisors held 5,104 shares of Amgen worth $1.85M as of Q2 2026.
  • Souders Financial Advisors sold 339 Amgen shares in Q2 2026, an estimated $116K.
  • Amgen made up 0.19% of Souders Financial Advisors's portfolio in Q2 2026, its #64 holding.
  • Souders Financial Advisors first reported a position in Amgen in Q3 2020 and has held it in 14 quarters since.
  • Souders Financial Advisors's Amgen position peaked at $4.89M in Q3 2024.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Souders Financial Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.